• The 9th meeting of the  Intergovernmental Negotiating Body (INB), held in Geneva, convened sessions for discussions on the following points:-

1. Focused on the accord between developing and developed countries for equitable access (based on the Nagoya Protocol).

2. Biopharmaceutical companies to pitch in for improving surveillance and research on potential pathogens of geographic diversity and importance.

3. Member states are to build on delivering equitable access under the joint statement.

4. Discussion on Pathogen- Access -and-benefit-sharing (PABS), to enable countries across the globe to coordinate research and development in prevention on all levels.

• The 77th World Health Assembly also amended the International Health Regulations (2005), foreseeing future global pandemics.

• The Berlin Declaration recommendations laid the groundwork to work upon further agreement with multi-stakeholder Partnerships and commit to the following:

1. Reservations for the production and distribution of vaccines

2. Enhance the availability of raw materials.

3. Technology transfer to prioritize research

4. Financial and technological support

• When we are faced with averting future pandemics from spiraling into catastrophic human crises, India can play a pivotal role in negotiating arguments and turning them into a reality.

Click here to read more